The dependent solution: anorexia and bulimia as defenses against dangerFRIEDRICHS, M.Women & therapy. 1988, Vol 7, Num 4, pp 53-73, issn 0270-3149Article

Ein Wenig gewürdigtes Protest- und Erbauungsstück : Rogers' Ponteach : or the Savages of America (1766)FRIEDRICHS, M.Zeitschrift für Anglistik und Amerikanistik. 1986, Vol 34, Num 2, pp 145-157, issn 0044-2305Article

Améliorer l'utilisation de l'électricité = Improving electricity utilisationFRIEDRICHS, M; UNTERWURZACHER, E.L' Observateur de l'OCDE (Print). 1989, Num 160, pp 26-30, issn 0304-3398Article

Treatment Targets in Multiple Sclerosis: The Ends and the Means European Charcot Foundation SymposiumHOMMES, O. R; FRIEDRICHS, M.Journal of the neurological sciences. 2008, Vol 274, Num 1-2, issn 0022-510X, 87 p.Conference Proceedings

Améliorer l'utilisation de l'électricitéFRIEDRICHS, M; UNTERWURZACHER, E.L' Observateur de l'OCDE (Print). 1989, Num 160, pp 26-30, issn 0304-3398Article

Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: Astrocytopathy as a common denominator in demyelinating disordersKIRA, Jun-Ichi.Journal of the neurological sciences. 2011, Vol 311, Num 1-2, pp 69-77, issn 0022-510X, 9 p.Conference Paper

Vitamin D: Evidence for its role as a prognostic factor in multiple sclerosisMOWRY, Ellen M.Journal of the neurological sciences. 2011, Vol 311, Num 1-2, pp 19-22, issn 0022-510X, 4 p.Conference Paper

Mending the brain: Stem cells and repair in multiple sclerosisHOMMES, O. R; FRIEDRICHS, M.Journal of the neurological sciences. 2008, Vol 265, Num 1-2, issn 0022-510X, 143 p.Conference Proceedings

Expanding autologous multipotent mesenchymal bone marrow stromal cellsBRINCHMANN, Jan E.Journal of the neurological sciences. 2008, Vol 265, Num 1-2, pp 127-130, issn 0022-510X, 4 p.Conference Paper

How to trace stem cells for MRI evaluation?DOUSSET, Vincent; TOURDIAS, Thomas; BROCHET, Bruno et al.Journal of the neurological sciences. 2008, Vol 265, Num 1-2, pp 122-126, issn 0022-510X, 5 p.Conference Paper

New targets for treatment of multiple sclerosisSTEINMAN, Lawrence.Journal of the neurological sciences. 2008, Vol 274, Num 1-2, pp 1-4, issn 0022-510X, 4 p.Conference Paper

Reconsidering clinical outcomes in Multiple Sclerosis : Relapses, impairment, disability and beyondD'SOUZA, M; KAPPOS, L; CZAPLINSKI, A et al.Journal of the neurological sciences. 2008, Vol 274, Num 1-2, pp 76-79, issn 0022-510X, 4 p.Conference Paper

Treatment strategies in multiple sclerosis: From pathophysiology to clinical practiceHOMMES, O. R; FRIEDRICHS, M.Journal of the neurological sciences. 2007, Vol 259, Num 1-2, issn 0022-510X, 137 p.Conference Proceedings

Approved drugs and their problems in patient care : Routes of administration and dosingCOOK, Stuart D.Journal of the neurological sciences. 2007, Vol 259, Num 1-2, pp 38-41, issn 0022-510X, 4 p.Conference Paper

¹H, ¹³C, and ¹⁵N NMR assignments and global folding pattern of the RNA-binding domain of the human hnRNP C proteinsWITTEKIND, M; GÖRLACH, M; FRIEDRICHS, M et al.Biochemistry (Easton). 1992, Vol 31, Num 27, pp 6254-6265, issn 0006-2960Article

A review of the health consequences of the vitamin D deficiency pandemicDOBNIG, Harald.Journal of the neurological sciences. 2011, Vol 311, Num 1-2, pp 15-18, issn 0022-510X, 4 p.Conference Paper

Characterization of the multiple sclerosis traits: Nuclear receptors (NR) impaired apoptosis pathway and the role of 1-alpha 25-dihydroxyvitamin D₃ACHIRON, Anat; FELDMAN, Anna; GUREVICH, Michael et al.Journal of the neurological sciences. 2011, Vol 311, Num 1-2, pp 9-14, issn 0022-510X, 6 p.Conference Paper

Herpesvirus active replication in multiple sclerosis A genetic control?GARCIA-MONTOJO, Marta; MARTINEZ, Alfonso; ARROYO, Rafael et al.Journal of the neurological sciences. 2011, Vol 311, Num 1-2, pp 98-102, issn 0022-510X, 5 p.Conference Paper

Endogenous or exogenous oligodendrocytes for remyelinationBLAKEMORE, W. F; IRVINE, K-A.Journal of the neurological sciences. 2008, Vol 265, Num 1-2, pp 43-46, issn 0022-510X, 4 p.Conference Paper

Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs) : A proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseasesKARUSSIS, Dimitrios; KASSIS, Ibrahim; KURKALLI, Basan Gowda S et al.Journal of the neurological sciences. 2008, Vol 265, Num 1-2, pp 131-135, issn 0022-510X, 5 p.Conference Paper

Plasticity and remodeling of brainCHOPP, Michael; YI LI; JING ZHANG et al.Journal of the neurological sciences. 2008, Vol 265, Num 1-2, pp 97-101, issn 0022-510X, 5 p.Conference Paper

Stem cell treatment in Amyotrophic Lateral SclerosisMAZZINI, Letizia; MARESCHI, Katia; FERRERO, Ivana et al.Journal of the neurological sciences. 2008, Vol 265, Num 1-2, pp 78-83, issn 0022-510X, 6 p.Conference Paper

The effects of natalizumab on the innate and adaptive immune system in the central nervous systemSTÜVE, Olaf.Journal of the neurological sciences. 2008, Vol 274, Num 1-2, pp 39-41, issn 0022-510X, 3 p.Conference Paper

Inflammatory demyelination and neurodegeneration in early multiple sclerosisCHARIL, Amaud; FILIPPI, Massimo.Journal of the neurological sciences. 2007, Vol 259, Num 1-2, pp 7-15, issn 0022-510X, 9 p.Conference Paper

Death receptor expression and function at the human blood brain barrierWOSIK, Karolina; BIEMACKI, Katarzyna; KHOUZAM, Marie-Pierre et al.Journal of the neurological sciences. 2007, Vol 259, Num 1-2, pp 53-60, issn 0022-510X, 8 p.Conference Paper